SK14722003A3 - Farmaceutická kombinácia obsahujúca buď kyselinu (S)-2-etoxy-3- [4-(2-{4-metánsulfonyloxyfenyl}-etoxy)fenyl]propánovú, alebo kyselinu 3-{4-[2-(4-terc-butoxykarbonylaminofenyl)etoxy]fenyl}- (S)-2-etoxypropánovú a sulfonylmočovinu - Google Patents

Farmaceutická kombinácia obsahujúca buď kyselinu (S)-2-etoxy-3- [4-(2-{4-metánsulfonyloxyfenyl}-etoxy)fenyl]propánovú, alebo kyselinu 3-{4-[2-(4-terc-butoxykarbonylaminofenyl)etoxy]fenyl}- (S)-2-etoxypropánovú a sulfonylmočovinu Download PDF

Info

Publication number
SK14722003A3
SK14722003A3 SK1472-2003A SK14722003A SK14722003A3 SK 14722003 A3 SK14722003 A3 SK 14722003A3 SK 14722003 A SK14722003 A SK 14722003A SK 14722003 A3 SK14722003 A3 SK 14722003A3
Authority
SK
Slovakia
Prior art keywords
ethoxy
phenyl
combination
sulfonylurea
pharmaceutically acceptable
Prior art date
Application number
SK1472-2003A
Other languages
English (en)
Slovak (sk)
Inventor
Peter Hman
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of SK14722003A3 publication Critical patent/SK14722003A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK1472-2003A 2001-06-01 2002-05-30 Farmaceutická kombinácia obsahujúca buď kyselinu (S)-2-etoxy-3- [4-(2-{4-metánsulfonyloxyfenyl}-etoxy)fenyl]propánovú, alebo kyselinu 3-{4-[2-(4-terc-butoxykarbonylaminofenyl)etoxy]fenyl}- (S)-2-etoxypropánovú a sulfonylmočovinu SK14722003A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0101982A SE0101982D0 (sv) 2001-06-01 2001-06-01 Pharmaceutical combination
PCT/SE2002/001036 WO2002100413A1 (en) 2001-06-01 2002-05-30 A PHARMACEUTICAL COMBINATION COMPRISING EITHER (S)-2-ETHOXY-3- [4-(2-{4-METHANE SULFONYL OXYPHENYL} ETHOXY) PHENYL] PROPANOIC ACID OR 3-{4-[2-(4-TERT- BUTOXY CARBONYL AMINOPHENYL) ETHOXY] PHENYL} -(s)-2-ETHOXY PROPANOIC ACID AND A SULONYLUREA

Publications (1)

Publication Number Publication Date
SK14722003A3 true SK14722003A3 (sk) 2004-08-03

Family

ID=20284364

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1472-2003A SK14722003A3 (sk) 2001-06-01 2002-05-30 Farmaceutická kombinácia obsahujúca buď kyselinu (S)-2-etoxy-3- [4-(2-{4-metánsulfonyloxyfenyl}-etoxy)fenyl]propánovú, alebo kyselinu 3-{4-[2-(4-terc-butoxykarbonylaminofenyl)etoxy]fenyl}- (S)-2-etoxypropánovú a sulfonylmočovinu

Country Status (21)

Country Link
US (1) US20040157927A1 (hu)
EP (1) EP1399166A1 (hu)
JP (1) JP2004532891A (hu)
KR (1) KR20040007624A (hu)
CN (1) CN1250226C (hu)
BR (1) BR0210127A (hu)
CA (1) CA2448763A1 (hu)
CO (1) CO5540382A2 (hu)
CZ (1) CZ20033235A3 (hu)
EE (1) EE200300583A (hu)
HU (1) HUP0401613A3 (hu)
IL (1) IL159035A0 (hu)
IS (1) IS7057A (hu)
MX (1) MXPA03011010A (hu)
NO (1) NO20035235D0 (hu)
PL (1) PL367890A1 (hu)
RU (1) RU2003136157A (hu)
SE (1) SE0101982D0 (hu)
SK (1) SK14722003A3 (hu)
WO (1) WO2002100413A1 (hu)
ZA (1) ZA200309263B (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008019169A (ja) * 2004-10-25 2008-01-31 Osaka Univ 新規ｐｐａｒ調節剤およびそのスクリーニング方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US5783556A (en) * 1996-08-13 1998-07-21 Genentech, Inc. Formulated insulin-containing composition
US6552055B2 (en) * 1996-12-11 2003-04-22 Dana-Farber Cancer Institute Methods and pharmaceutical compositions for inhibiting tumor cell growth
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
US5859037A (en) * 1997-02-19 1999-01-12 Warner-Lambert Company Sulfonylurea-glitazone combinations for diabetes
SE9801992D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl-2-hydroxypropionic acid derivative I
SE9801990D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl propionic acid derivatives and analogs

Also Published As

Publication number Publication date
IS7057A (is) 2003-11-28
CN1250226C (zh) 2006-04-12
US20040157927A1 (en) 2004-08-12
CN1537008A (zh) 2004-10-13
PL367890A1 (en) 2005-03-07
EE200300583A (et) 2004-02-16
NO20035235D0 (no) 2003-11-25
HUP0401613A3 (en) 2007-11-28
HUP0401613A2 (hu) 2004-11-29
CZ20033235A3 (cs) 2004-12-15
RU2003136157A (ru) 2005-05-20
KR20040007624A (ko) 2004-01-24
WO2002100413A1 (en) 2002-12-19
CA2448763A1 (en) 2002-12-19
ZA200309263B (en) 2005-03-11
SE0101982D0 (sv) 2001-06-01
BR0210127A (pt) 2004-06-08
EP1399166A1 (en) 2004-03-24
CO5540382A2 (es) 2005-07-29
IL159035A0 (en) 2004-05-12
MXPA03011010A (es) 2004-02-27
JP2004532891A (ja) 2004-10-28

Similar Documents

Publication Publication Date Title
Thompson et al. Pramlintide, a synthetic analog of human amylin, improves the metabolic profile of patients with type 2 diabetes using insulin
CA2345524C (en) Combinations for diabetes which contain a sulfonylurea, a glitazone and a biguanide
CN101631859B (zh) 用于治疗代谢综合征的新组合物
US20020177602A1 (en) Antidiabetic formulation and method
KR20020038758A (ko) 대사 장애, 특히 당뇨병 또는 당뇨병 관련 질환 또는증상의 치료 방법
EP0957923A1 (en) Sulfonylurea-glitazone synergistic combinations for diabetes
SK287810B6 (sk) Farmaceutický prostriedok obsahujúci nízkodávkovú kombináciu metformínu a glyburidu
SK14722003A3 (sk) Farmaceutická kombinácia obsahujúca buď kyselinu (S)-2-etoxy-3- [4-(2-{4-metánsulfonyloxyfenyl}-etoxy)fenyl]propánovú, alebo kyselinu 3-{4-[2-(4-terc-butoxykarbonylaminofenyl)etoxy]fenyl}- (S)-2-etoxypropánovú a sulfonylmočovinu
SK14712003A3 (sk) Farmaceutická kombinácia obsahujúca buď kyselinu (S)-2-etoxy-3- [4-(2-{4-metánsulfonyloxyfenyl}-etoxy)fenyl]propánovú, alebo kyselinu 3-{4-[2-(4-terc-butoxykarbonylaminofenyl)etoxy]fenyl}- (S)-2-etoxypropánovú a inzulín
EP1404309B1 (en) A pharmaceutical combination comprising either (s)-2-ethoxy-3- 4-(2- 4-methane sulfonyl oxyphenyl ethoxy) phenyl| propanoic acid or 3- 4- 2- (4-tert-butoxy carbonyl aminophenyl) ethoxy| phenyl -(s)-2-ethoxy propanoic acid and a biguanide drug
AU2002309399A1 (en) A pharmaceutical combination comprising either (S)-2-ethoxy -3 [4-(2- {4-methane sulfonyl oxyphenyl} ethoxy)phenyl] propanoic acid or 3-{4-[2- (4-tert-butoxy carbonylamino phenyl) ethoxy] phenyl}-(S)-2-ethoxy propanoic acid and insulin
AU2002309398A1 (en) A pharmaceutical combination comprising either (S)-2-ethoxy-3- [4-(2-{4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{4-[2-(4-tert- butoxy carbonyl aminophenyl) ethoxy] phenyl} -(s)-2-ethoxy propanoic acid and a sulonylurea
AU2002258332A1 (en) A pharmaceutical combination comprising either (S)-2-ethoxy-3- [4-(2- {4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{4-[2- (4-tert-butoxy carbonyl aminophenyl) ethoxy] phenyl} -(S)-2-ethoxy propanoic acid and a biguanide drug
Mahler Metformin: actions and indications for use in non-insulin-dependent diabetes mellitus
JP2002535369A (ja) 糖尿病を治療するための組成物及び方法

Legal Events

Date Code Title Description
FC9A Refused patent application